Faron Pharmaceuticals sees positive data from phase 1 BEXMAB trial

Faron Pharmaceuticals Ltd on Wednesday said data from its phase 1 BEXMAB study has shown positive data.

The Finland-based clinical-stage biopharmaceutical company said three of five patients in the...

Related Keywords

Finland ,London ,City Of ,United Kingdom ,Harvey Dorset ,Marie Louise Fjallskog ,Us Food Drug Administration ,Faron Pharmaceuticals Ltd On ,Alliance News Ltd ,Alliance News ,Pharmaceuticals Ltd ,Drug Administration ,Medical Officer Marie Louise Fjallskog ,All Rights ,Markets ,